Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IMMUNOMEDICS INCIMMU · Entity 145732 | Director | January 08, 2017 | January 10, 2017 |
| Verastem, Inc.VSTM · Entity 5242 | Director · President and CEO | December 31, 2018 | February 13, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IMMUNOMEDICS INC
Report date January 08, 2017 · Filed January 10, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.73 · Expires 2024-01-08 | Direct | 22,500 |
Reported balance
After 2017-01-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-01-08 · Grant · Acquired 22,500 · Balance 22,500 |
Verastem, Inc.
Report date December 31, 2018 · Filed February 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 213,234 |
Ending reported balance
After 2018-01-25 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-01-25 · Gift · Disposed 4,000 · Balance 217,234 Row 2 · 2018-01-25 · Gift · Disposed 4,000 · Balance 213,234 |
| Common StockSEC Table I · non-derivative | IndirectBy trust | 9,000 |
Reported balance
After 2018-01-25 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2018-01-25 · Gift · Acquired 4,000 · Balance 9,000 F1: Shares held by The Claudia Forrester 2001 Trust, the beneficiary of which is Claudia Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy trust | 9,000 |
Reported balance
After 2018-01-25 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2018-01-25 · Gift · Acquired 4,000 · Balance 9,000 F2: Shares held by The Iona Forrester 2001 Trust, the beneficiary of which is Iona Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held by The Claudia Forrester 2001 Trust, the beneficiary of which is Claudia Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F2: Shares held by The Iona Forrester 2001 Trust, the beneficiary of which is Iona Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2019 Filed Jan 7, 2019 16:43 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 240,000 | $0.00 Strike: $3.51 | $0.00 |
DisclosureSEC source: 0000904454-19-000024 · edgar.xml · derivative · entry 2 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 Underlying: Common Stock · 240,000 shares Expires 2029-01-03 F2 · derivative.exercise_date: The option vests as to: (a) 40% of the shares upon the date on which the closing price per share of the common stock is at least $10.00 on at least 20 (whether or not consecutive) of the prior 30 trading days, (b) 40% of the shares shall vest upon the date on which the closing price per share of the common stock is at least $15.00 on at least 20 (whether or not consecutive) of the prior 30 trading days, and (c) 20% of the shares shall vest upon the date on which the closing price per share of the common stock is at least $20.00 on at least 20 (whether or not consecutive) of the prior 30 trading days, provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 16:43 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 240,000 | $0.00 Strike: $3.51 | $0.00 |
DisclosureSEC source: 0000904454-19-000024 · edgar.xml · derivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 Underlying: Common Stock · 240,000 shares Expires 2029-01-03 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of January 1, 2019 (the "Commencement Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Commencement Date until the fourth anniversary of the Commencement Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 18:52 UTC | Verastem, Inc. VSTM · Entity 5242 | PurchaseCommon Stock | 2,000 | $7.00 | $14,000.00 |
DisclosureSEC source: 0000904454-18-000629 · edgar.xml · nonDerivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,234 Read SEC document |
| September 27, 2018 Filed Oct 1, 2018 18:39 UTC | Verastem, Inc. VSTM · Entity 5242 | PurchaseCommon Stock | 10,000 | $7.00 | $70,000.00 |
DisclosureSEC source: 0000904454-18-000613 · edgar.xml · nonDerivative · entry 2 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,234 Read SEC document |
| September 27, 2018 Filed Oct 1, 2018 18:39 UTC | Verastem, Inc. VSTM · Entity 5242 | PurchaseCommon Stock | 500 | $7.00 | $3,500.00 |
DisclosureSEC source: 0000904454-18-000613 · edgar.xml · nonDerivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,234 Read SEC document |
| September 24, 2018 Filed Oct 2, 2018 18:52 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0000904454-18-000629 · edgar.xml · derivative · entry 4 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2028-01-05 F3 · shares: On January 5, 2018, the Reporting Person was granted an option to purchase 150,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 30,000 shares. 40% of the performance criteria was met on September 24, 2018, resulting in vesting of the option as to 60,000 shares. Read SEC document |
| April 06, 2018 Filed Jun 4, 2018 17:55 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001104659-18-038053 · a4.xml · derivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President and C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-01-05 F1 · balance_after: On January 5, 2018, the Reporting Person was granted an option to purchase 150,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 30,000 shares. Read SEC document |
| January 25, 2018 Filed Feb 13, 2019 17:02 UTC | Verastem, Inc. VSTM · Entity 5242 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-19-000229 · edgar.xml · nonDerivative · entry 4 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 9,000 F2 · ownership.nature: Shares held by The Iona Forrester 2001 Trust, the beneficiary of which is Iona Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 25, 2018 Filed Feb 13, 2019 17:02 UTC | Verastem, Inc. VSTM · Entity 5242 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-19-000229 · edgar.xml · nonDerivative · entry 3 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 9,000 F1 · ownership.nature: Shares held by The Claudia Forrester 2001 Trust, the beneficiary of which is Claudia Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 25, 2018 Filed Feb 13, 2019 17:02 UTC | Verastem, Inc. VSTM · Entity 5242 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-19-000229 · edgar.xml · nonDerivative · entry 2 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,234 Read SEC document |
| January 25, 2018 Filed Feb 13, 2019 17:02 UTC | Verastem, Inc. VSTM · Entity 5242 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-19-000229 · edgar.xml · nonDerivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,234 Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 17:44 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001104659-18-001508 · a4.xml · derivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2028-01-05 F1 · derivative.exercise_date: 25% of this option will vest on January 1, 2019 and 6.25% of this option will vest at the end of each successive three-month period thereafter until January 1, 2022. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 16:01 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001104659-17-058282 · a4.xml · derivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President, CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 50,000 shares Expires 2026-06-14 F1 · balance_after: On June 14, 2016, the Reporting Person was granted an option to purchase 100,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by the end of June, 2017 and the end of June, 2018. 50% of the performance criteria was met on September 19, 2017, resulting in vesting of the option as to 50,000 shares. Read SEC document |
| May 26, 2017 Filed Feb 6, 2018 19:05 UTC | Verastem, Inc. VSTM · Entity 5242 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-006910 · a5.xml · nonDerivative · entry 4 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By The Iona Forrester 2001 Trust Disclosed balance after: 5,000 F2 · kind: This transaction involved a gift of securities by the Reporting Person to The Iona Forrester 2001 Trust, the beneficiary of which is Iona Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 26, 2017 Filed Feb 6, 2018 19:05 UTC | Verastem, Inc. VSTM · Entity 5242 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-006910 · a5.xml · nonDerivative · entry 3 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,734 F2 · kind: This transaction involved a gift of securities by the Reporting Person to The Iona Forrester 2001 Trust, the beneficiary of which is Iona Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 26, 2017 Filed Feb 6, 2018 19:05 UTC | Verastem, Inc. VSTM · Entity 5242 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-006910 · a5.xml · nonDerivative · entry 2 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By The Claudia Forrester 2001 Trust Disclosed balance after: 5,000 F1 · kind: This transaction involved a gift of securities by the Reporting Person to The Claudia Forrester 2001 Trust, the beneficiary of which is Claudia Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 26, 2017 Filed Feb 6, 2018 19:05 UTC | Verastem, Inc. VSTM · Entity 5242 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-006910 · a5.xml · nonDerivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,734 F1 · kind: This transaction involved a gift of securities by the Reporting Person to The Claudia Forrester 2001 Trust, the beneficiary of which is Claudia Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 09, 2017 Filed Jan 11, 2017 17:00 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 360,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001104659-17-001973 · a4.xml · derivative · entry 1 Forrester Robert · CIK 0001319890 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 360,000 shares Expires 2027-01-09 F1 · derivative.exercise_date: 25% of this option will vest on January 9, 2018 and 6.25% of this option will vest at the end of each successive three-month period thereafter until January 9, 2021. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:15 UTC | IMMUNOMEDICS INC IMMU · Entity 145732 | GrantStock Options (right to buy) · Derivative | 22,500 | $0.00 Strike: $3.73 | $0.00 |
DisclosureSEC source: 0001104659-17-001802 · a4.xml · derivative · entry 1 Forrester Robert · CIK 0001319890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock, par value $0.01 per share · 22,500 shares Expires 2024-01-08 Read SEC document |
| October 29, 2016 Filed Nov 1, 2016 20:12 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001104659-16-153853 · a4.xml · derivative · entry 1 Forrester Robert · CIK 0001319890 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-06-14 F1 · balance_after: On June 14, 2016, the Reporting Person was granted an option to purchase 100,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by the end of June, 2017 and the end of June, 2018. 50% of the performance criteria was met on October 29, 2016, resulting in vesting of the option as to 50,000 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.